Related Experiment Video
Updated: Jul 7, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Endocarditis in Adults with Congenital Heart Disease
Andrea Busti1, Giuseppe Annoni1, Carlo Pace Napoleone2
1Pediatric and Congenital Cardiology, Regina Margherita Children's Hospital, Torino, Italy.
Insights
Infective endocarditis (IE) poses significant risks for adults with congenital heart disease (CHD). Early diagnosis and tailored prevention strategies are crucial for managing this high-risk population.
Area of Science:
- Cardiology
- Infectious Diseases
- Congenital Heart Disease
Background:
- Infective endocarditis (IE) is a leading cause of death in patients with congenital heart disease (CHD).
- Adults with CHD have an elevated lifetime risk of IE due to complex cardiac anatomy, prosthetic materials, and interventions.
- IE in CHD patients presents unique epidemiological, microbiological, and clinical challenges compared to the general population.
Purpose of the Study:
- To review the distinct aspects of IE in patients with CHD.
- To highlight diagnostic challenges and management strategies specific to this population.
- To emphasize the importance of preventive measures for IE in CHD patients.
Main Methods:
- Review of current literature on IE in CHD.
- Analysis of epidemiological, microbiological, and clinical data.
- Discussion of diagnostic modalities and treatment approaches.
Main Results:
- Streptococcal species and Staphylococcus aureus are the most common pathogens.
- Diagnosis is complicated by complex anatomy and prosthetic material, necessitating high clinical suspicion and advanced imaging.
- Prolonged antimicrobial therapy and frequent surgical interventions are often required.
- Complications at presentation are more common in CHD patients.
Conclusions:
- IE management in CHD requires a multidisciplinary approach, considering unique patient factors.
- Multimodality imaging and a high index of suspicion are vital for accurate diagnosis.
- Preventive strategies, including antibiotic prophylaxis and hygiene, are paramount for reducing IE incidence in this vulnerable group.
Abstract:
Infective endocarditis (IE) remains a major cause of morbidity and mortality in patients with congenital heart disease (CHD). Advances in medical and surgical care have led to a growing population of adults with CHD who carry a substantially higher lifetime risk of IE than the general population. This increased susceptibility reflects the combined effects of abnormal intracardiac flow patterns, the frequent presence of prosthetic material or intracardiac devices, and repeated surgical and transcatheter interventions. The epidemiology, microbiology, clinical presentation, and management of IE in CHD differ in several important aspects from those observed in patients without CHD. Streptococcal species and Staphylococcus aureus account for the majority of IE cases. Diagnosis is often challenging due to complex cardiac anatomy and the presence of prosthetic material, and therefore it requires a high index of suspicion and multimodality imaging. Medical therapy usually requires prolonged antimicrobial therapy. Surgical intervention is more frequently required than in non-CHD populations, reflecting both the burden of prosthetic material and the higher rate of complications at presentation. Preventive strategies, including meticulous dental and skin hygiene and appropriate antibiotic prophylaxis, remain the cornerstone of IE management in this high-risk population.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Endocarditis IV: Nursing Management
Mitral Stenosis I: Introduction
